These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2697413

  • 1. Allogeneic BMT for AML in Zagreb.
    Labar B, Bogdanić V, Nemet D, Mrsić M, Pavletić Z, Zupancić S, Radman I, Aurer I.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():86-7. PubMed ID: 2697413
    [No Abstract] [Full Text] [Related]

  • 2. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
    Mrsić M, Labar B, Bogdanić V, Nemet D, Pavletić Z, Plavsić F, Dobrić I, Kastelan A, Marusić M, Zupancić-Salek S.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
    [No Abstract] [Full Text] [Related]

  • 3. Allogeneic bone marrow transplantation for ALL in Zagreb.
    Bogdanić V, Labar B, Nemet D, Mrsić M, Pavetić Z, Aurer I.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():88-9. PubMed ID: 2697414
    [No Abstract] [Full Text] [Related]

  • 4. Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol.
    Zittoun R, Mandelli F, De Witte T, Willemze R, Tura S.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():56-8. PubMed ID: 2202470
    [No Abstract] [Full Text] [Related]

  • 5. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G, Leverger G, Leblanc T, Nelken B, Baruchel A, Landman-Parker J, Thuret I, Bergeron C, Bordigoni P, Esperou-Bourdeau H, Perel Y, Vannier JP, Schaison G.
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.
    Carella AM, Piatti G, Frassoni F, Maraone MP, Van Lint MT, Bacigalupo A.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469
    [No Abstract] [Full Text] [Related]

  • 7. Post remission therapy in acute myeloid leukaemia (AML): the Medical Research Council experience in the UK.
    Rees JK, Gray RG.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():70-1. PubMed ID: 2697405
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC.
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

  • 11. How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease.
    Powles R, Treleaven J, Millar J, Gordon-Smith EC, Tiley C, Findlay M, Teo C, Duncombe A, Robinson G.
    Bone Marrow Transplant; 1991 Jun; 7 Suppl 2():9-10. PubMed ID: 1878737
    [No Abstract] [Full Text] [Related]

  • 12. Autologous BMT for AML without purging.
    Burnett AK.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():76-8. PubMed ID: 2697408
    [No Abstract] [Full Text] [Related]

  • 13. Autologous and allogeneic bone marrow transplantation for childhood acute nonlymphoblastic leukemia.
    Vowels M, Stevens M, Tiedemann K, Brown R.
    Transplant Proc; 1992 Feb; 24(1):184-5. PubMed ID: 1539237
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG.
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [Abstract] [Full Text] [Related]

  • 16. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
    Hirabayashi N, Goto S, Ishii M, Yuge M, Mitsuma A, Noda N.
    Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
    [Abstract] [Full Text] [Related]

  • 17. Comparison of intensive consolidation therapy and autologous bone marrow transplantation in acute myeloid leukaemia. The Leiden experience.
    Willemze R, Fibbe WE, Richel DJ, Kluin-Nelemans JC, Zwaan FE.
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():73. PubMed ID: 2697407
    [No Abstract] [Full Text] [Related]

  • 18. [Allogeneic bone marrow transplantation in acute myeloid leukemia (AML): results in 14 patients].
    Kos M, Hinterberger W, Gadner H, Haas O, Kalhs P, Panzer S, Geissler K, Schwarzinger I, Hinterberger-Fischer M, Neumann E.
    Wien Klin Wochenschr; 1987 Apr 03; 99(7):217-22. PubMed ID: 3296468
    [Abstract] [Full Text] [Related]

  • 19. Acute myeloid leukemia and the position of autologous stem cell transplantation.
    Breems DA, Löwenberg B.
    Semin Hematol; 2007 Oct 03; 44(4):259-66. PubMed ID: 17961725
    [Abstract] [Full Text] [Related]

  • 20. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F.
    Bone Marrow Transplant; 1999 Mar 03; 23(5):443-50. PubMed ID: 10100557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.